111 related articles for article (PubMed ID: 7876386)
1. Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.
Hussain MJ; Lau JY; Williams R; Vergani D
J Clin Pathol; 1994 Dec; 47(12):1112-5. PubMed ID: 7876386
[TBL] [Abstract][Full Text] [Related]
2. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Rossol S; Torre F; Wong PY; Gallati H; Portmann B; Williams R
Gastroenterology; 1995 May; 108(5):1453-63. PubMed ID: 7729638
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
5. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection.
Fang JW; Shen WW; Meager A; Lau JY
Am J Gastroenterol; 1996 Apr; 91(4):748-53. PubMed ID: 8677942
[TBL] [Abstract][Full Text] [Related]
6. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
Xie Y; Zhao H; Dai WS; Xu DZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
8. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
[TBL] [Abstract][Full Text] [Related]
9. Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.
Wu JC; Lee SD; Wang JY; Ting LP; Tsai YT; Tsay SH; Tong MJ
Arch Pathol Lab Med; 1987 Feb; 111(2):181-4. PubMed ID: 3545139
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
11. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.
Chang JJ; Thompson AJ; Visvanathan K; Kent SJ; Cameron PU; Wightman F; Desmond P; Locarnini SA; Lewin SR
Hepatology; 2007 Nov; 46(5):1332-40. PubMed ID: 17924445
[TBL] [Abstract][Full Text] [Related]
12. Markers of disease activity in chronic hepatitis B virus infection.
Yalcin K; Degertekin H; Yildiz F; Celik Y
Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
[TBL] [Abstract][Full Text] [Related]
13. Smaller reduction of hepatitis B virus DNA in liver tissue than in serum in patients losing HBeAg.
Tripodi G; Larsson SB; Norkrans G; Lindh M
J Med Virol; 2017 Nov; 89(11):1937-1943. PubMed ID: 28464339
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
16. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products.
Lau JY; Bird GL; Alexander GJ; Williams R
Clin Invest Med; 1993 Jun; 16(3):226-36. PubMed ID: 8365050
[TBL] [Abstract][Full Text] [Related]
18. Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic hepatitis B.
Liu X; Chen JM; Lou JL; Huang YX; Yan Y; Sun GZ; Li N
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421011
[TBL] [Abstract][Full Text] [Related]
19. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection.
Sheron N; Lau J; Daniels H; Goka J; Eddleston A; Alexander GJ; Williams R
J Hepatol; 1991 Mar; 12(2):241-5. PubMed ID: 2051003
[TBL] [Abstract][Full Text] [Related]
20. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
